NeuroBo Pharmaceuticals Gross Profit 1970-1969 | MTVA
NeuroBo Pharmaceuticals gross profit from 1970 to 1969. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
NeuroBo Pharmaceuticals Annual Gross Profit
(Millions of US $) |
NeuroBo Pharmaceuticals Quarterly Gross Profit
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
